|
21
|
113
|
8gwnG |
A mechanism for sars-cov-2 rna capping and its inhibition by nucleotide analogue inhibitors |
|
230
|
931
|
8gwiA |
A mechanism for sars-cov-2 rna capping and its inhibition by nucleotide analogue inhibitors |
|
53
|
187
|
8gwgB |
A mechanism for sars-cov-2 rna capping and its inhibition by nucleotide analogue inhibitors |
|
69
|
306
|
8ey2A |
Cryo-em structure of sars-cov-2 main protease c145s in complex with n-terminal peptide |
|
91
|
301
|
7zv7A |
Crystal structure of sars cov-2 main protease in complex with an inhibitor 57 |
|
24
|
116
|
8bsdB |
Sars-cov-2 nsp10-16 methyltransferase in complex with tubercidin |
|
201
|
926
|
8gwoA |
A mechanism for sars-cov-2 rna capping and its inhibition by nucleotide analogue inhibitors |
|
91
|
301
|
8bsdA |
Sars-cov-2 nsp10-16 methyltransferase in complex with tubercidin |
|
61
|
306
|
7zb8A |
Crystal structure of sars-cov-2 main protease (mpro) variant k61a at 2.48 a resolution |
|
82
|
305
|
7zv8A |
Crystal structure of sars cov-2 main protease in complex with an inhibitor 58 |
|
85
|
306
|
7zb7A |
Crystal structure of sars-cov-2 main protease (mpro) variant y54f at 1.63 a resolution |
|
63
|
306
|
7zb6A |
Crystal structure of sars-cov-2 main protease (mpro) variant c44s at 2.12 a resolution |
|
131
|
438
|
8ev3D |
Ytm1 associated 60s nascent ribosome (-fkbp39) state 1b |
|
115
|
439
|
8eupD |
Ytm1 associated 60s nascent ribosome state 1a |
|
51
|
187
|
8gwoB |
A mechanism for sars-cov-2 rna capping and its inhibition by nucleotide analogue inhibitors |
|
21
|
215
|
8etgD |
Fkbp39 associated 60s nascent ribosome state 3 |
|
21
|
72
|
8gwoC |
A mechanism for sars-cov-2 rna capping and its inhibition by nucleotide analogue inhibitors |
|
134
|
438
|
8esrD |
Ytm1 associated nascent 60s ribosome (-fkbp39) state 2 |
|
102
|
593
|
8gwoE |
A mechanism for sars-cov-2 rna capping and its inhibition by nucleotide analogue inhibitors |
|
72
|
306
|
7lcrA |
Improved feline drugs as sars-cov-2 mpro inhibitors: structure-activity studies & micellar solubilization for enhanced bioavailability |
|
123
|
445
|
8ethD |
Ytm1 associated 60s nascent ribosome state 1b |
|
60
|
439
|
8etiD |
Fkbp39 associated 60s nascent ribosome state 1 |
|
226
|
926
|
7uo9A |
Sars-cov-2 replication-transcription complex bound to utp, in a pre-catalytic state |
|
281
|
929
|
7uoeA |
Sars-cov-2 replication-transcription complex bound to ctp, in a pre-catalytic state |
|
238
|
927
|
7uo4A |
Sars-cov-2 replication-transcription complex bound to remdesivir triphosphate, in a pre-catalytic state |
|
87
|
301
|
7zv5A |
Crystal structure of sars cov-2 main protease in complex with an inhibitor 4 |
|
86
|
300
|
8f46A |
Crystal structure of sars-cov-2 3cl protease in complex with a dimethyl phenyl sulfane inhibitor (cyano warhead) |
|
23
|
73
|
7uoeC |
Sars-cov-2 replication-transcription complex bound to ctp, in a pre-catalytic state |
|
22
|
73
|
7uo9C |
Sars-cov-2 replication-transcription complex bound to utp, in a pre-catalytic state |
|
55
|
188
|
7uoeB |
Sars-cov-2 replication-transcription complex bound to ctp, in a pre-catalytic state |
|
49
|
187
|
7uo4B |
Sars-cov-2 replication-transcription complex bound to remdesivir triphosphate, in a pre-catalytic state |
|
46
|
190
|
7uo9B |
Sars-cov-2 replication-transcription complex bound to utp, in a pre-catalytic state |
|
19
|
73
|
7uo4C |
Sars-cov-2 replication-transcription complex bound to remdesivir triphosphate, in a pre-catalytic state |
|
86
|
299
|
8e4rA |
Room-temperature x-ray structure of sars-cov-2 main protease h41a miniprecursor mutant in complex with gc373 |
|
25
|
117
|
8az9B |
Sars-cov-2 non-structural protein-1 (nsp1) in complex with 1-(2-(3-chlorophenyl)thiazol-4-yl)-n-methylmethanamine |
|
24
|
118
|
8a4yA |
Sars-cov-2 non-structural protein-1 (nsp1) in complex with n-(2,3-dihydro-1h-inden-5-yl)acetamide |
|
21
|
117
|
8asqB |
Sars-cov-2 non-structural protein-1 (nsp1) in complex with n-methyl-1-(4-(thiophen-2-yl)phenyl)methanamine |
|
84
|
300
|
8f44A |
Crystal structure of sars-cov-2 3cl protease in complex with a dimethyl phenyl sulfane inhibitor |
|
79
|
306
|
7q5fA |
Crystal structure of f2f-2020216-01x bound to the main protease (3clpro/mpro) of sars-cov-2. |
|
45
|
127
|
7xc3A |
Crystal structure of sars-cov-2 nsp3 macrodomain 3 (sars-unique domain-m) |
|
24
|
117
|
8aysB |
Sars-cov-2 non-structural protein-1 (nsp1) in complex with 4-(2-aminothiazol-4-yl)phenol |
|
22
|
117
|
8az8B |
Sars-cov-2 non-structural protein-1 (nsp1) in complex with 2-(benzylamino)ethan-1-ol |
|
23
|
118
|
8a55A |
Structure of n-terminal sars-cov-2 nonstructural protein 1 (nsp1) at atomic resolution |
|
42
|
127
|
7xc4A |
Crystal structure of sars-cov-2 nsp3 macrodomain 3 (sars-unique domain-m) in complex with oxaprozin |
|
89
|
300
|
8f45A |
Crystal structure of sars-cov-2 3cl protease in complex with a phenyl dimethyl sulfane inhibitor (cyclopropyl ketoamide warhead) |
|
84
|
299
|
8e4jA |
Room-temperature x-ray structure of sars-cov-2 main protease h41a miniprecursor mutant |
|
24
|
118
|
8aywB |
Sars-cov-2 non-structural protein-1 (nsp1) in complex with (s)-1-(4-chlorophenyl)ethan-1-amine |
|
177
|
682
|
8dvsA |
Cryo-em structure of rig-i bound to the end of ohslr30 (+atp) |
|
76
|
306
|
7q5eA |
Crystal structure of f2f-2020209-00x bound to the main protease (3clpro/mpro) of sars-cov-2. |
|
81
|
303
|
8eyjA |
Crystal structure of uncleaved sars-cov-2 main protease c145s mutant in complex with nirmatrelvir |
